ChromaCode To Show New Data In Oncology and Blood Based Monitoring at the Association for Molecular Pathology 2023 Annual Meeting and Expo
CARLSBAD, Calif., Oct. 31, 2023 /PRNewswire/ -- ChromaCode, Inc., a pioneering genomics multiplexing platform company developing accessible and affordable solutions for laboratories, will present new data during a Corporate workshop and present two accepted scientific abstracts at the Association for Molecular Pathology (AMP) 2023 annual meeting, being held at the Salt Palace Convention Center in Salt Lake City, Utah, from November 14-18, 2023.
- "The ChromaCode team is proud to participate in this year's preeminent conference for molecular diagnostics, AMP 2023.
- At the Corporate Workshop, we will be revealing new data showcasing the potential of HDPCR enabled multiplexing and ChromaCode software in transplant and minimal residual disease.
- We look forward to engaging with fellow attendees at these presentations and at our Booth (1700)" stated Mark McDonough, Chief Executive Officer at ChromaCode.
- Attendees can expect insights into the latest software tools, data analysis techniques, and their potential to enhance precision and accuracy in molecular testing.